Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safely Stopping Pre-Medications in Paclitaxel for Breast Cancer
NCT04862585Phase 3Completed
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Oct 2021
- Primary completion
- Jun 2024
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection in breast cancer, sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Started Oct 2021; status: completed.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04862585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04862585.